Cyclical Neuroactive Steroid Changes, Arousal, and Proximal Suicide Risk: An Experimental Approach

Condition:   Suicidal Ideation Interventions:   Drug: Estradiol Transdermal Patch 0.1 mg/24 hrs;   Drug: Oral Micronized Progesterone 200mg;   Drug: Inactive Clear Patch;   Drug: Placebo capsule Sponsor:   University of Illinois at Chicago Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials